(47 days)
The St. Jude Medical CPS Direct™ Universal slittable outer guide catheter is designed for intracardiac access of the venous system of the heart and to serve as a conduit during implantation for the delivery of contrast medium and St. Jude Medical devices (including implantable left heart leads and delivery tools), and support of fluids where minimizing blood loss is essential. In addition, CPS Direct Universal slittable outer guide catheters can work with inner catheters as a system
The CPS Direct™ Universal slittable outer catheter facilitates left heart lead delivery during cardiac resynchronization therapy (CRT) procedures. The CPS Direct Universal provides access to the coronary venous system and acts as a conduit for contrast medium. The CPS Direct TM Universal slittable outer catheters will be available in the same working lengths, 47 and 54 cm as the predicate and will be available with the same number of curves as the predicate. The key design features of the CPS Direct™ Universal slittable outer catheters have only undergone minimal changes to the inner diameter, outer diameter, and design of shaft and hub to accommodate change in diameter of the catheter and the accessories have not changed (See Section 9). The key design features are listed below:
- Braid reinforced, varying durometer PEBAX shaft with molded proximal . hub.
- Atraumatic distal soft tip. .
- The outside surface and inside surfaces of the catheter shaft are coated . with Siloxane to provide lubricity during use.
- The distal end of the shaft has gold marker bands and tungsten stripes for . fluoroscopic visibility.
- Hub contains a sideport with extension tubing for contrast delivery, . aspiration, or saline flush using a 3-way stopcock.
- Accessories such as VBT used to assist the insertion of SJM Devices . (leads, guidewires, inner catheters, etc)
This document is a 510(k) summary for a medical device called the "CPS Direct™ Universal slittable outer catheter". The purpose of this submission is to gain clearance for this device, which has undergone only minimal design changes compared to its predicate device, the CPS Direct® SLII slittable outer catheter (K092075).
Here's the information extracted from the provided text, formatted as requested:
Acceptance Criteria and Device Performance
This 510(k) pertains to a medical device (catheter) and does not include acceptance criteria or reported device performance in the form of metrics like sensitivity, specificity, or AUC, as would be common for AI/ML-driven diagnostic devices. Instead, the acceptance criteria are implicit in meeting design and performance specifications to demonstrate substantial equivalence to a predicate device.
The "reported device performance" section of the 510(k) states that:
| Acceptance Criteria (Implicit) | Reported Device Performance |
|---|---|
| Meet predetermined design and performance specifications. | "Completion of all verification and validation activities demonstrated that the candidate devices meet their predetermined design and performance specifications..." |
| Substantial equivalence to the predicate device, CPS Direct® SLII slittable outer catheter (K092075). | "...and that the products are substantially equivalent to the predicate devices (Appendix 1)." |
| Function in accordance with product specifications. | "The results of the verification and validation tests and the risk analysis have demonstrated the CPS Direct™ Universal slittable outer catheter functions in accordance with product specifications." |
| No significant changes in technological characteristics that would raise new questions of safety and effectiveness compared to the predicate device. | "The device has the same technological characteristics as the currently marketed CPS Direct® SLII slittable outer catheter, with only minimal changes to the inner diameter, outer diameter, and design of shaft and hub to accommodate change in diameter of the catheter and the accessories have not changed." |
1. A table of acceptance criteria and the reported device performance:
As indicated above, the acceptance criteria for this type of medical device clearance are primarily related to proving substantial equivalence to a predicate device through verification and validation activities, rather than specific performance metrics (e.g., accuracy, sensitivity) typically seen with AI/ML systems.
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
The provided text does not specify sample sizes for test sets, data provenance, or whether the study was retrospective or prospective. The document mentions "verification and validation activities" and "non-clinical test summary," implying engineering and bench-top testing rather than clinical study data with human subjects or retrospective/prospective data from a specific origin.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
The provided text does not mention the use of experts to establish 'ground truth' in the context of diagnostic performance, as this is a medical device clearance for a catheter based on substantial equivalence and engineering testing, not an AI/ML diagnostic system.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
The provided text does not mention any adjudication methods. This concept is not applicable to the type of device and clearance described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
The provided text does not mention a multi-reader multi-case (MRMC) comparative effectiveness study, nor does it discuss human reader performance or AI assistance. This is not an AI/ML-driven device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
The provided text does not describe an algorithm-only standalone performance study. This is a hardware medical device (catheter) and the concept of an "algorithm" or "human-in-the-loop" is not relevant here.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc):
For this type of device, "ground truth" would equate to the established engineering specifications, material properties, and functional requirements verified through testing. The document does not specify a type of ground truth like expert consensus or pathology, but rather implies that the predicate device's established performance and the new device's adherence to its own specifications through "verification and validation activities" serve as the basis for claiming equivalence.
8. The sample size for the training set:
The provided text does not mention a "training set" sample size. This information is relevant for AI/ML models, not for this type of medical catheter clearance.
9. How the ground truth for the training set was established:
The provided text does not discuss a "training set" or how its ground truth was established, as it is not an AI/ML device.
{0}------------------------------------------------
510(k) Summary
The purpose of this special 510(K) is to gain clearance for the CPS Direct™ Universal slittable outer catheter. The key design features of the CPS Direct™ Universal slittable outer catheter have only undergone minimal design changes to the catheter to increase the inner diameter, outer diameter and hub of the catheter as compared to the predicate, CPS Direct® SLII slittable outer catheter (K092075).
| Submitter: | St. Jude Medical, CRMD |
|---|---|
| Address: | 15900 Valley View CtSylmar, CA 91342 |
| Phone: | 818 493 2960 |
| Fax: | 818 493 3615 |
| Contact Person: | Colleen Canan |
| Trade Name/ProprietaryName: | CPS Direct™ Universal slittable outer catheter |
| Common Name: | Percutaneous CatheterModel Numbers: DS2C018, DS2C019, DS2C020, DS2C021, DS2C022, DS2C023, DS2C024, DS2C025, DS2C026, DS2C027, DS2C028, DS2C029, DS2C030 |
| Classification: | Class II, 21 CFR 870.1250 |
| Legally marketed deviceto which your firm isclaiming equivalence: | CPS Direct® SLII slittable outer catheter (K092075) |
Device Description:
The device description of the CPS Direct™ Universal slittable outer catheter is as follows.
- . The CPS Direct™ Universal slittable outer catheter facilitates left heart lead delivery during cardiac resynchronization therapy (CRT) procedures. The CPS Direct Universal provides access to the coronary venous system and acts as a conduit for contrast medium. The CPS Direct TM Universal slittable outer catheters will be available in the same working lengths, 47 and 54 cm as the predicate and will be available with the same number of curves as the predicate. The key design features of the CPS Direct™ Universal slittable outer catheters have only undergone minimal changes to the inner diameter, outer diameter, and design of shaft and hub to accommodate change in diameter of the catheter and the accessories have not changed (See Section 9). The key design features are listed below:
{1}------------------------------------------------
- Braid reinforced, varying durometer PEBAX shaft with molded proximal . hub.
- Atraumatic distal soft tip. .
- The outside surface and inside surfaces of the catheter shaft are coated . with Siloxane to provide lubricity during use.
- The distal end of the shaft has gold marker bands and tungsten stripes for . fluoroscopic visibility.
- Hub contains a sideport with extension tubing for contrast delivery, . aspiration, or saline flush using a 3-way stopcock.
- Accessories such as VBT used to assist the insertion of SJM Devices . (leads, guidewires, inner catheters, etc)
The indication for use is as follows:
The St. Jude Medical CPS Direct™ Universal slittable outer guide catheter is designed for intracardiac access of the venous system of the heart and to serve as a conduit during implantation for the delivery of contrast medium and St. Jude Medical devices (including implantable left heart leads and delivery tools), and support of fluids where minimizing blood loss is essential. In addition, CPS Direct Universal slittable outer guide catheters can work with inner catheters as a system
Technological Characteristics of the Device Compared to the Predicate Device:
The device has the same technological characteristics as the currently marketed CPS Direct® SLII slittable outer catheter, with only minimal changes to the inner diameter, outer diameter, and design of shaft and hub to accommodate change in diameter of the catheter and the accessories have not changed.
Non-clinical Test Summary:
Completion of all verification and validation activities demonstrated that the candidate devices meet their predetermined design and performance specifications and that the products are substantially equivalent to the predicate devices (Appendix 1).
Conclusion (Statement of Equivalence):
The results of the verification and validation tests and the risk analysis have demonstrated the CPS Direct™ Universal slittable outer catheter functions in accordance with product specifications. St. Jude Medical considers the CPS Direct™ Universal slittable outer catheter to be substantially equivalent to the legally marketed predicate device, the CPS Direct® SLII slittable outer catheter cleared in 510(k) K092075.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 20, 2013
St. Jude Medical C/O Colleen Canan 15900 Valley View Ct. Sylmar, CA 91342
Re: K130257
Trade/Device Name: CPS Direct™ Universal Slittable Outer Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Catheter, Percutaneous Regulatory Class: Class II Product Code: DQY Dated: January 29, 2013 Received: February 1, 2013
Dear Ms. Canan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Ms. Colleen Canan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Owen P. Faris -S
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
.
.
Indications for Use Statement
.
| 510(k)Number(if known) | K130257 |
|---|---|
| Device Name | CPS Direct™ Universal slittable outer catheter |
| Indicationsfor Use | The St. Jude Medical CPS Direct™ Universal slittable outer guide catheter is designed for intracardiac access of the venous system of the heart and to serve as a conduit during implantation for the delivery of contrast medium and St. Jude Medical devices (including implantable left heart leads and delivery tools), and support of fluids where minimizing blood loss is essential. In addition, CPS Direct Universal slittable outer guide catheters can work with inner catheters as a system |
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE
IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use(Per 21 CFR 801. 109) | X OR Over-The-Counter Use ______ |
|---|---|
| ------------------------------------------- | ---------------------------------- |
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).